home | where we are | e-mail us

Adam Geneva logo


Welcome to ADAM
a
CERN spin-off company

ADAM aims to be a centre
of excellence for research
and industrialization of applications
to medicine and industry.

Radiations and medicine

HISTORY OF IONIZING RADIATIONS IN MEDICINE

At the end of the 19th century several discoveries concerned ionizing radiation.
From the very beginning these innovations had an enormous impact on the medical practice for the two complementary applications to which radiation is connected: the medical imaging for diagnostics, and radiotherapy for cancer (and other diseases) treatment.

Medical Imaging for diagnostic (detectors used to reproduce images of the internal organs)

The X-rays. In November 1895 Röntgen discovered that accelerating electrons against a lead target some “unknown” rays were produced and he called them X-rays.
He presented their diagnostic properties the first time only one month later taking the first radiography of his wife’s hand.
Today X-rays and CT scans are indispensable in diagnostic.

 

The Cyclotron. In 1929 Ernest Lawrence invented the cyclotron, a particle accelerator which was intended for research in physics but was soon recognized as a unique tool for medical and biological studies.
Today these machines are producing the radioisotopes for the PET (Positron Emission Tomography) and in general for nuclear medicine scanning in hundreds of facilities around the world.

Radiotherapy (cancer and other diseases treatment with ionizing radiation)

The first pioneering treatments with X-rays. After Röntgen’s discovery, it did not take long to the physicians to apply the x-rays in pioneering cancer treatments. The first attempts of therapy of skin cancer took place at the beginning of the last century. Today 40% of cured tumors were treated with either X-rays alone or in combination with surgery or chemotherapy.

  

Natural radioactivity. Only few months after the discovery of the X-ray, Henri Becquerel (left) discovered the natural radioactivity.
Pierre and Maria Curie discovered  in 1898 the radium, a radioactive source of gamma rays.
Radiotherapy based on radioactive cobalt 60 would have been used many years later after the second world war for treatment with cobalt units.
Today the majority of the cobalt units have been replaced by electron linear accelerators.

Nuclear medicine. Ernest Lawrence’s cyclotron was used in pioneering studies by his own brother John to produce radioactive phosphorus 32 to treat leukemia.
He also used the cyclotron to produce neutron for solid cancer treatments. Today radioactive material is widely used in treatments named Brachytherapy where the sources are placed directly in contact with the tumor.

IONIZING RADIATION AND CANCER

The primary goals of radiotherapy are the delivery of the dose to induce the death of the tumor cell preserving the harm to the surrounding healthy tissue due to the radiation itself.

  • The efficacy of the ionizing radiation for the local control of the tumors has been proven soon after the discoveries of the radiations. Although the interaction between radiation and matter are well known it is particularly difficult to understand processes and mechanisms that link the delivery of the radiation to a target to the local control of the tumor. This complex task is still ongoing nowadays and requires an wide multidisciplinary approach.
     
  • The ionizing radiations used for therapy are photons (X-rays and gamma rays) and electrons in conventional radiotherapy and basically protons and carbon ions in today’s hadron therapy (often also called particle therapy). The radiation interacting with the atoms of the body (tumor and healthy tissue) induces ionization. Radiation of different nature produce ionizations of different density and characteristics.
     
  • The ionization mainly interacts with the biological matter through the formation of free radicals which, due to their high reactivity, may induce DNA brakes. The complexity of the DNA damage is linked to the ionization characteristics.
     
  • The cell reaction, which depends on the extension and severity of the damage, involves mechanisms to lead to repair or death.
     
  • The ultimate goal of radiotherapy is to deliver to the target the minimum dose capable of killing up to the last tumor cell and, at the same time, to preserve organ at risk and healthy tissue which surround the tumor. The local control of the tumor is the result of this chain of effects.

CONVENTIONAL RADIOTHERAPY (X-ray) AND THE ORIGINAL APPROACH OF HADRON THERAPY

The primary goal of radiotherapy is to deliver to the tumor the necessary dose and, at the same time, to avoid the damage of the surrounding healthy tissue.
The dose necessary to cure the patients is evaluated in dose escalation studies where the total dose and number of fractions for a certain tumor are optimized to reach the highest rate of cure limiting secondary effects. The dose is the amount of energy delivered to the tumor per unit mass. Fractionation is the term used to indicate the number of times in which the total dose is delivered. Generally a patient receives a fraction of the dose per day and the treatment can last from few days to several weeks depending on type and stage of the tumor.

  • In conventional radiotherapy with photons, the level of dose to the healthy tissue is maintained low by increasing the number of irradiation fields. This result is obtained rotating the linear accelerator around the patient. In the most recent methods of Intensity Modulated Radiation Therapy, IMRT, the radiation is optimized by distributing the dose trough up to 10 nonisocentric fields.

  • The curve which describes the energy released from the hadrons shows a peak right at the end of the penetration of the beam. It is called Bragg peak.
     
  • Because of the Bragg peak and, in the case of carbon ions, of the very well defined the lateral shape of the beam, it is possible to conform the dose precisely to the shape of the tumor with a limited number of irradiation fields. It is possible to drastically limit the dose to the sensitive organs, which could be otherwise severely damaged from the irradiation. In general the total dose delivered to the healthy tissue is sensibly reduced in respect to conventional therapy.
     
  • The idea of using hadrons for cancer treatment dates back to 1946, and was originally proposed by the Robert Wilson. Hadron therapy was first put into practice at the Lawrence Berkeley Laboratory (LBL) in the USA, where approximately 30 patients were treated with protons in the period 1954–1957.
     
  • Heavy particle radiotherapy is performed today basically with protons and carbon ions. The number of medical centers which perform the therapy in the work is rapidly increasing for both particles.
     
  • Carbon ions are more effective in the interaction with the biological targets when the are close to the end of their path. Because of this characteristics is it possible to further decrease the dose to the healthy tissue and therefore reduce the side effects.
     
  • Tumors which have reduced vascularization and therefore less oxygenation are less sensitive to photon and proton irradiation. Instead the level of oxygen in the treated tissue is not a critical parameter for irradiation with carbon ions. This therapy becomes the indicated treatment for all the solid tumor lacking of oxygen.

 

 top of page